Work

177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinoma

Year: 2013

Type: article

Source: Nuclear Medicine Communications

DOI: 10.1097/mnm.0b013e328362d2b6

Authors: Lei Jiang, Zheng Miao, Hongguang Liu, Gang Ren, Ande Bao, Cathy S. Cutler, Hongcheng Shi, Zhen Cheng

Institutions: Shanghai Medical College of Fudan University, Fudan University, Zhongshan Hospital, Stanford Cancer Institute, Stanford University, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, University of Missouri

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Science Foundation, U.S. Department of Energy

OpenAlex ID: W2033882358

FWCI: 0.775

Cites: 25

Cited by: 17

Related to: 10